Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Interleukin Genetics Inc

+ Add to Watchlist

ILIU:US

0.1490 USD 0.0010 0.67%

As of 20:10:00 ET on 02/27/2015.

Company Profile for Interleukin Genetics Inc (ILIU)

Interleukin Genetics, Inc. develops and commercializes genetic diagnostic tests and medical research tools. The Company's PST, a test predictive of risk for periodontal disease, is currently available in the United States. Interleukin also develops and licenses its medical research tools, such as BioFusion, to pharmaceutical companies for use in drug discovery and development.

Contact Information

Interleukin Genetics Inc

135 Beaver Street
Waltham, MA 02452
United States
Phone: 1-781-398-0700
Fax: 1-781-398-0720

Key Executives for Interleukin Genetics Inc (ILIU)

Kenneth S Kornman "Ken"Pres/CEO/Chief Scientific OfcrStephen J DipalmaInterim CFO
Scott A SnyderChief Marketing Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil